Meisha R Sampson - FDA Investigator Report

Designation: SUPERVISORY CONSUMER SAFETY

Duty Station: Indianapolis IN 46204

Organizations: DHHS FDA OC OGROP OIP

Overview Statistics

98
Total Inspections
65
Total 483s Issued
3
Warning Letters Issued

Inspection Details

Longest Inspection: 21 days
Shortest Inspection: 1 days
Average Length: 3.9 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Meisha R Sampson's Recent Inspections

DateCompanyCityCountryFEI Number483
2024-07-03MSI Express IncPortageUnited States3016112728
2018-03-26Shandong Analysis and Test CenterJinanChina3011060456
2018-03-21Frog Prince (China) Daily Chemicals Co.,LtdZhangzhouChina3009903116
2018-01-25Guangzhou Hanpu Pharmaceutical Co. Ltd.GuangzhouChina3007088627
2018-01-12Inner Mongolia Huashu Biological Technology Co., Ltd.Tongliao CityChina1000308605
2017-12-22AutekBio FTZBeijingChina3014058509
2017-11-17Qilu Pharmaceutical (Hainan) Co. LtdHaikouChina3008250362
2017-10-25Suzhou Amerigen PharmaceuticalSuzhouChina3007751274
2017-10-11Beijing Rimeng Biological Technology Co. Ltd.BeijingChina3005660579
2017-09-14Yicheng Goto Pharmaceuticals Co., LtdYicheng CityChina3004459466

Sign Up to get the complete report.

Download 483s and EIRs for Meisha R Sampson

Meisha R Sampson - Co-Inspectors

Meisha R Sampson's Active Locations

  • United States
  • China
  • India
  • Romania
  • Sweden
  • Israel
  • France
  • Netherlands
  • United Kingdom
  • Spain
  • Dominican Republic (the)
  • Italy
  • Germany
  • Australia
  • Guyana

Meisha R Sampson's Year-wise Inspection Count

  • 2013:24 inspections
  • 2014:26 inspections
  • 2015:19 inspections
  • 2016:13 inspections
  • 2017:11 inspections
  • 2018:4 inspections
  • 2024:1 inspections
Last Updated: 2025-05-14 06:11:22